Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1.

Yoshida C, Yoshida F, Sears DE, Hart SM, Ikebe D, Muto A, Basu S, Igarashi K, Melo JV.

Blood. 2007 Feb 1;109(3):1211-9. Epub 2006 Oct 3.

PMID:
17018862
[PubMed - indexed for MEDLINE]
Free Article
2.

Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation.

Melo JV, Deininger MW.

Hematol Oncol Clin North Am. 2004 Jun;18(3):545-68, vii-viii. Review.

PMID:
15271392
[PubMed - indexed for MEDLINE]
3.

BCR/ABL, DNA damage and DNA repair: implications for new treatment concepts.

Skorski T.

Leuk Lymphoma. 2008 Apr;49(4):610-4. doi: 10.1080/03093640701859089. Review.

PMID:
18398719
[PubMed - indexed for MEDLINE]
4.

Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: from molecular redox mechanisms to health implications.

Rodrigues MS, Reddy MM, Sattler M.

Antioxid Redox Signal. 2008 Oct;10(10):1813-48. doi: 10.1089/ars.2008.2071. Review.

PMID:
18593226
[PubMed - indexed for MEDLINE]
5.

Important therapeutic targets in chronic myelogenous leukemia.

Kantarjian HM, Giles F, Quintás-Cardama A, Cortes J.

Clin Cancer Res. 2007 Feb 15;13(4):1089-97. Review.

PMID:
17317816
[PubMed - indexed for MEDLINE]
Free Article
6.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk